Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.
作者信息
de Bono D
机构信息
Department of Medicine, University of Leicester, Glenfield Hospital.
出版信息
Br Heart J. 1994 Jun;71(6):504-7. doi: 10.1136/hrt.71.6.504.
Abstract
摘要
相似文献
1
Significance of raised plasma concentrations of tissue-type plasminogen activator and plasminogen activator inhibitor in patients at risk from ischaemic heart disease.血浆组织型纤溶酶原激活物和纤溶酶原激活物抑制剂浓度升高在缺血性心脏病高危患者中的意义。
Br Heart J. 1994 Jun;71(6):504-7. doi: 10.1136/hrt.71.6.504.
2
Hemostatic factors and the risk of myocardial infarction.止血因素与心肌梗死风险
N Engl J Med. 1995 Aug 10;333(6):389; author reply 389-90.
3
Importance of thrombosis and thrombolysis in silent ischaemia: comparison of patients with acute myocardial infarction and unstable angina.血栓形成与溶栓在无症状性缺血中的重要性：急性心肌梗死与不稳定型心绞痛患者的比较。
Br Heart J. 1994 Feb;71(2):151-5. doi: 10.1136/hrt.71.2.151.
4
Plasminogen activator inhibitor-1 and tissue plasminogen activator and incident AF: Data from the PREVEND study.纤溶酶原激活物抑制剂-1、组织纤溶酶原激活物与房颤发病率：来自预防和逆转肾病发展（PREVEND）研究的数据
Int J Cardiol. 2018 Dec 1;272:208-210. doi: 10.1016/j.ijcard.2018.08.029. Epub 2018 Aug 10.
5
Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease.缺血性心脏病男性患者体内组织型纤溶酶原激活物及其抑制剂、血管性血友病因子抗原和前列环素刺激因子的昼夜变化。
Br Heart J. 1993 Feb;69(2):121-4. doi: 10.1136/hrt.69.2.121.
6
Plasminogen activator and plasma activator inhibitor-1 in young women with polycystic ovary syndrome.多囊卵巢综合征年轻女性中的纤溶酶原激活物和血浆激活物抑制剂-1
Int J Gynaecol Obstet. 2008 Mar;100(3):285-6. doi: 10.1016/j.ijgo.2007.09.019. Epub 2007 Nov 26.
7
[Dehydroepiandrosterone therapy in men with angiographically verified coronary heart disease: the effects on plasminogen activator inhibitor-1 (PAI-1), tissue plasminogen activator (tPA) and fibrinogen plasma concentrations].[脱氢表雄酮对经血管造影证实的冠心病男性患者的治疗：对纤溶酶原激活物抑制剂-1（PAI-1）、组织纤溶酶原激活物（tPA）和血浆纤维蛋白原浓度的影响]
Endokrynol Pol. 2007 May-Jun;58(3):213-9.
8
Tissue plasminogen activator (t-PA) and plasminogen activator inhibitor type 1 (PAI-1) in diabetic foot syndrome.糖尿病足综合征中的组织型纤溶酶原激活剂（t-PA）和1型纤溶酶原激活剂抑制剂（PAI-1）
Adv Med Sci. 2017 Mar;62(1):87-91. doi: 10.1016/j.advms.2016.07.007. Epub 2017 Feb 11.
9
Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.1型糖尿病患者血浆中组织型纤溶酶原激活物和纤溶酶原激活物抑制剂活性正常
Horm Metab Res. 1992 Nov;24(11):516-9. doi: 10.1055/s-2007-1003378.
10
Effects of the Magenstrasse and Mill operation for obesity on plasma plasminogen activator inhibitor type 1, tissue plasminogen activator, fibrinogen and insulin.
Pathophysiol Haemost Thromb. 2002 Jan-Feb;32(1):40-3. doi: 10.1159/000057287.
引用本文的文献
1
Endogenous tPA levels: A biomarker for discriminating hemorrhagic stroke from ischemic stroke and stroke mimics.内源性 tPA 水平：鉴别出血性卒中和缺血性卒中和卒中模拟的生物标志物。
Ann Clin Transl Neurol. 2024 Nov;11(11):2877-2890. doi: 10.1002/acn3.52197. Epub 2024 Sep 10.
2
Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease.血浆脂蛋白(a)和组织纤溶酶原激活物与动脉粥样硬化性心血管疾病风险增加相关。
Heliyon. 2022 Jun 30;8(7):e09836. doi: 10.1016/j.heliyon.2022.e09836. eCollection 2022 Jul.
3
Novel Biomarkers Detected by Proteomics Predict Death and Cardiovascular Events in Hemodialysis Patients.蛋白质组学检测到的新型生物标志物可预测血液透析患者的死亡和心血管事件。
Biomedicines. 2022 Mar 22;10(4):740. doi: 10.3390/biomedicines10040740.
4
Omega-3 fatty acids attenuate cardiovascular effects of short-term exposure to ambient air pollution.ω-3 脂肪酸可减轻短期接触环境空气污染对心血管的影响。
Part Fibre Toxicol. 2022 Feb 9;19(1):12. doi: 10.1186/s12989-022-00451-4.
5
Ozone exposure is associated with acute changes in inflammation, fibrinolysis, and endothelial cell function in coronary artery disease patients.臭氧暴露与冠心病患者炎症、纤溶和内皮细胞功能的急性变化有关。
Environ Health. 2017 Nov 21;16(1):126. doi: 10.1186/s12940-017-0335-0.
6
Plasminogen activator inhibitor and the risk of cardiovascular disease: The Framingham Heart Study.纤溶酶原激活物抑制剂与心血管疾病风险：弗雷明汉心脏研究
Thromb Res. 2016 Apr;140:30-35. doi: 10.1016/j.thromres.2016.02.002. Epub 2016 Feb 3.
7
The Role of Hemostatic Factors in Atherosclerosis in Patients with Chronic Renal Disease.止血因子在慢性肾病患者动脉粥样硬化中的作用
Electron Physician. 2015 Sep 16;7(5):1270-6. doi: 10.14661/1270. eCollection 2015 Sep.
8
Plasma Biomarkers of Inflammation, Endothelial Function and Hemostasis in Cerebral Small Vessel Disease.脑小血管病中炎症、内皮功能和止血的血浆生物标志物
Cerebrovasc Dis. 2015;40(3-4):157-64. doi: 10.1159/000438494. Epub 2015 Aug 8.
9
Acute coronary syndromes: from the laboratory markers to the coronary vessels.急性冠状动脉综合征：从实验室标志物到冠状动脉血管
Biomark Insights. 2007 Feb 7;1:123-30.
10
Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction.组织型纤溶酶原激活物抗原可预测急性心肌梗死后中期左心室收缩末期容积。
J Thromb Thrombolysis. 2010 May;29(4):421-8. doi: 10.1007/s11239-009-0383-6.
本文引用的文献
1
Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis.昼夜纤维蛋白溶解节律的证据；采用一种测量自然纤维蛋白溶解的简单方法。
Clin Sci. 1957 Nov;16(4):645-50.
2
Plasminogen activator inhibitor: a risk factor for myocardial infarction in diabetic patients.纤溶酶原激活物抑制剂：糖尿病患者心肌梗死的一个危险因素。
Br Heart J. 1993 Mar;69(3):228-32. doi: 10.1136/hrt.69.3.228.
3
4
Increased fibrinolytic activity in the intima of atheromatous coronary arteries: protection at a price.动脉粥样硬化性冠状动脉内膜中纤维蛋白溶解活性增加：以代价换取的保护。
Cardiovasc Res. 1993 May;27(5):882-5. doi: 10.1093/cvr/27.5.882.
5
Regulation of PAI-1 gene expression in vivo.体内纤溶酶原激活物抑制因子-1（PAI-1）基因表达的调控
Thromb Haemost. 1993 Jul 1;70(1):135-7.
6
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.诺斯威克公园心脏研究中的纤溶活性、凝血因子与缺血性心脏病的长期发病率
Lancet. 1993 Oct 30;342(8879):1076-9. doi: 10.1016/0140-6736(93)92062-x.
7
Endogenous tissue-type plasminogen activator and risk of myocardial infarction.内源性组织型纤溶酶原激活剂与心肌梗死风险
Lancet. 1993 May 8;341(8854):1165-8. doi: 10.1016/0140-6736(93)90998-v.
8
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.心肌梗死年轻幸存者中组织型纤溶酶原激活物快速抑制剂的血浆水平升高。
N Engl J Med. 1985 Dec 19;313(25):1557-63. doi: 10.1056/NEJM198512193132501.
9
Endothelial cells produce a latent inhibitor of plasminogen activators that can be activated by denaturants.内皮细胞产生一种纤溶酶原激活物的潜在抑制剂，该抑制剂可被变性剂激活。
J Biol Chem. 1985 Sep 25;260(21):11581-7.
10
Different types of plasminogen activator inhibitors in plasma and platelets in pregnant women.孕妇血浆和血小板中不同类型的纤溶酶原激活物抑制剂
Br J Haematol. 1986 Feb;62(2):215-20. doi: 10.1111/j.1365-2141.1986.tb02924.x.
Zotero 插件